Shqiponja Ferizaj
About Shqiponja Ferizaj
Shqiponja Ferizaj is a Product Specialist in Immunology & Fibrosis at Bristol Myers Squibb in Berlin, Germany, with a background in biochemistry and experience in scientific roles at AstraZeneca, Proteros biostructures GmbH, and Charité.
Title
Shqiponja Ferizaj holds the title of Product Specialist Immunology & Fibrosis. She is currently employed at Bristol Myers Squibb in Berlin, Deutschland in this specialized role.
Current Position at Bristol Myers Squibb
Since April 2021, Shqiponja Ferizaj has been with Bristol Myers Squibb, taking on responsibilities as a Product Specialist in Immunology & Fibrosis. In this role, she works primarily from Berlin, contributing to the company's ongoing efforts in these critical areas of medical research and product development.
Previous Roles in the Pharmaceutical Industry
Before joining Bristol Myers Squibb, Shqiponja worked at Santis im Auftrag von AstraZeneca from 2019 to 2021. She served as a Wissenschaftlicher Außendienst Diabetes in Munich, providing scientific sales and support in the field of diabetes. Prior to this, she worked as a Wissenschaftlicher Mitarbeiter at Proteros biostructures GmbH from 2017 to 2019, where she was involved in scientific research and development.
Academic Positions and Research Experience
In 2017, Shqiponja was a Tutor (Lehrassistent) at Ludwig-Maximilians Universität München for three months, assisting in the teaching of biochemical subjects. That same year, she worked as an Undergraduate Research Fellow at Charité's Comprehensive Cancer Center in Berlin, gaining valuable research experience in cancer studies over a three-month period.
Education and Academic Background
Shqiponja Ferizaj completed her Master of Science (MS) in Biochemistry from Ludwig-Maximilians Universität München between 2015 and 2017. She achieved her Bachelor of Science (BS) in Chemistry and Biochemistry from the same institution, studying from 2011 to 2015. Her strong academic background laid the foundation for her career in the pharmaceutical and biotech industries.